Compound ID | 1362
RB1
| Spectrum of activity: | Gram-negative |
| Details of activity: | Escherichia coli, S.typhimurium and A. baumanii |
| Institute where first reported: | Roche Products Limitted |
| Year first mentioned: | 2020 |
| Highest development stage: | Preclinical |
| External links: | |
| Citation: | https://mbio.asm.org/content/11/4/e01340-20 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.